• Call Us+91-9216325808
  • Email us bdm@dmpharmaglobal.com
request a callback

News

Home / News
Telangana Life Sciences Policy 2026–2030 Targets $25Bn Investment

Telangana Launches Next-Gen Life Sciences Policy 2026–2030 to Attract $25 Billion Investment

Telangana has announced an ambitious roadmap to transform itself into one of the world’s leading life sciences de […]

Read More
Indian Pharma Industry Gets a Fresh Boost as Government Pushes Manufacturing and Export Growth

Indian Pharma Industry Gets a Fresh Boost as Government Pushes Manufacturing and Export Growth

The Indian pharmaceutical industry has witnessed a significant policy-drive […]

Read More
US & European Regulators Issue AI Guidelines for Drug Development | Pharma Innovation Update

US and European Regulators Set Principles for ‘Good AI Practice’ in Drug Development

Artificial intelligence (AI) is rapidly transforming the global pharmaceutical landscape. Recognizing both its poten […]

Read More
Delhi High Court, diabetes FDC ban, Type II Diabetes Mellitus, fixed dose combination drugs, Glimepiride Pioglitazone Metformin, Drugs and Cosmetics Act 1940, Section 26A, DTAB recommendations, pharma regulatory news India, Indian pharmaceutical industry, drug safety regulations, anti-diabetic medicines, pharma manufacturing India, monopoly medicine company in India, pharma contract manufacturing company

Delhi High Court Restores Ban on Certain Type II Diabetes FDCs: Legal, Regulatory, and Industry Implications

[…]

Read More
Generic Semaglutide Patent Expiry Unlocks ₹50,000 Cr Opportunity for Pharma Industry

Generic Semaglutide Patent Expiry Unlocks Rs. 50,000 Cr Opportunity for Pharma Industry

The upcoming patent expiry of semaglutide, a leading GLP-1 therapy […]

Read More
Budget for 'pharmacy of the world'

Union Budget 2026: Strengthening India’s Vision as the “Pharmacy of the World”

India has steadily earned its reputation as the “Pharmacy of the World” […]

Read More
Health Ministry Excludes Syrups from OTC List

Health Ministry Moves to Exclude Syrups from OTC List: What It Means for the Indian Pharma Industry

[…]

Read More
Statins Reduce Death Risk in Type 2 Diabetes Patients

Anti-Cholesterol Medicines Can Reduce Death Risk in Type 2 Diabetes Patients

New medical research shows that anti-cholesterol medicines called statins […]

Read More
Changes in PCD Pharma Franchise Industry Next Year | Future Trends in India

Key Changes Expected in the PCD Pharma Franchise Industry Next Year

[…]

Read More
obesity treatment drugs india, obesity medicine market india, glp 1 drugs india, weight management pharma industry, lifestyle disease drugs india, pharmaceutical industry growth india, metabolic disorder treatment, diabetes and obesity drugs, indian pharma innovation, obesity led disease burden

Obesity Treatment Drugs Emerging as a Major Growth Driver for the Indian Pharma Industry

India’s pharmaceutical industry is entering a new phase of transformation, driven by the rising burden of lifesty […]

Read More
Call Us Whats App Send Enquiry